Focus group and Delphi process: Stroke and potential drug-drug Interactions (pDDI) in the neurological Intensive Care Unit (NICU)

Introduction: The clinical significance of potential drug-drug interactions (pDDIs), especially in the intensive care unit (ICU) manifested mostly as adverse drug reactions. Aim: The goal of this research was to conduct a focus group, in which the participants were decisionmakers in acute ischemic stroke patient treatment. Also, the aim was to reach a consensus, due to the Delphi process, between neurologists and clinical pharmacologists regarding this highly vulnerable group of patients. Material and Methods: In this academic research, so-called applied focus group (the goal was to reach practical decisions) and clinical focus group (determining motives, predeterminations, bias, prejudice and analyzing the behavior leading to a certain outcome) was done. Results: Continuing medical education of neurologists is needed regarding pDDIs and the use of an online pDDIs checker. Certain groups of patients with AIS are at particular risk of exposure to pDDIs. Certain drug groups are more likely to interact with other drugs. Conclusions: Defining medical recommendations/guidelines on evidence base medicine about pDDIs in patients with AIS would significantly contribute to reducing their frequency in this vulnerable patient population.

• Publication year

  2021

• Venue

  Hospital Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.5937/hpimj2102041a
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis

  2020cited by this paper
• Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions - Results of a multicenter Delphi study.

  2020cited by this paper
• Artificial Intelligence in Drug Treatment.

  2020cited by this paper
• Drug–Drug Interactions with Direct Oral Anticoagulants

  2020cited by this paper
• Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital

  2019cited by this paper
• Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey

  2019cited by this paper
• Amiodarone in the aged

  2019cited by this paper
• Hospital Pharmacists' Perceptions and Decision-Making Related to Drug-Drug Interactions.

  2019cited by this paper
• Use of DOACs in real-world challenging settings: a Delphi Consensus from Italian cardiologists.

  2019cited by this paper
• Evaluation of Potential Drug–Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis

  2019influential reference
• Effect of an educational intervention on the number potential drug-drug interactions

  2019cited by this paper
• Characteristic of drug-related problems and pharmacists’ interventions in a stroke unit in Thailand

  2019cited by this paper
• Past, Present, and Future of Drug–Drug Interactions

  2019cited by this paper
• Co-medication and potential drug interactions among patients with epilepsy.

  2019cited by this paper
• Review of Statistical Methodologies for Detecting Drug–Drug Interactions Using Spontaneous Reporting Systems

  2019influential reference
• Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria

  2018cited by this paper
• Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic.

  2018cited by this paper
• Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases

  2018cited by this paper
• Predicting potential drug-drug interactions on topological and semantic similarity features using statistical learning

  2018cited by this paper
• A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly

  2018cited by this paper
• Potential Drug–Drug Interactions with Antimicrobials in Hospitalized Patients: A Multicenter Point-Prevalence Study

  2018cited by this paper
• Drug Interactions With Oral Inhaled Medications

  2018cited by this paper
• Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions.

  2018cited by this paper
• Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments

  2017cited by this paper
• Life‐threatening drug interactions: what the physician needs to know

  2017cited by this paper
• Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis

  2017influential reference
• How to use the nominal group and Delphi techniques

  2016cited by this paper
• Neurologist knowledge about interactions between antiepileptic drugs and contraceptive methods

  2016cited by this paper
• Antifungal therapy: drug-drug interactions at your fingertips.

  2016cited by this paper
• Drug interactions involving antiepileptic drugs: assessment of the consistency among three drug compendia and FDA-approved labels.

  2015cited by this paper
• Recommendations to improve the usability of drug-drug interaction clinical decision support alerts

  2015cited by this paper
• Checklist for standardized reporting of drug–drug interaction management guidelines

  2013cited by this paper
• [Essential knowledge of drugs for neurologists on pharmacokinetics and drug development in global aspects to the world].

  2013cited by this paper
• Drug-related problems and factors influencing acceptance of clinical pharmacologists` alerts in a large cohort of neurology inpatients.

  2012cited by this paper
• Physicians' reported needs of drug information at point of care in Sweden.

  2012cited by this paper
• Relevance of drug-drug interaction in the ICU - perceptions of intensivists and pharmacists.

  2012cited by this paper
• Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients.

  2011cited by this paper
• Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity

  2010cited by this paper
• Drug–Drug Interactions Mediated Through P‐Glycoprotein: Clinical Relevance and In Vitro–In Vivo Correlation Using Digoxin as a Probe Drug

  2009cited by this paper
• A Mixed Method Study of the Merits of E-Prescribing Drug Alerts in Primary Care

  2008cited by this paper
• Potential determinants of prescribers' drug-drug interaction knowledge.

  2008cited by this paper
• Focus group discussion: a tool for health and medical research.

  2008cited by this paper
• Prescribers’ Knowledge of and Sources of Information for Potential Drug-Drug Interactions

  2008cited by this paper
• Interaction Between Selective Serotonin Reuptake Inhibitors and Nonsteroidal Antiinflammatory Drugs: Review of the Literature

  2006cited by this paper
• Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.

  2004cited by this paper
• Pharmacokinetic and Pharmacodynamic Considerations When Treating Patients with Sepsis and Septic Shock

  2002cited by this paper

• No citing papers are available for this paper.